NCT00485407View on ClinicalTrials.gov

Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine

PHASE3CompletedINTERVENTIONAL
Enrollment

377

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

June 30, 2005

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Atomoxetine Hydrochloride

Trial Locations (2)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Scottsdale

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Vancouver

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00485407 - Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine | Biotech Hunter | Biotech Hunter